Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism

Bin Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Haitao Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Acta Pharmaceutica Sinica B
May 17, 2024
10.1016/j.apsb.2024.05.014
Cited by 33

Related Papers

Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer
|Oncotarget|2016|61
Discussion on Current Pollution Status andLegislation of Environmental Hormone in China
|Procedia Environmental Sciences|2011|10
GSH-responsive nanoparticles enhance ovarian cancer chemo-immunotherapy via DNA damage repair pathway inhibition and cGAS-STING pathway activation
|Nano Today|2025|8
Corrigendum to “GSH-responsive nanoparticles enhance ovarian cancer chemo-immunotherapy via DNA damage repair pathway inhibition and cGAS-STING pathway activation” [Nano Today 62 (2025) 102729]
|Nano Today|2025|0